Clinical Trial Update: PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial) [Phase 4]

View source ↗

Summary

The Phase 4 PAF-HEFT trial investigating permanent atrial fibrillation in heart failure was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Atrial Fibrillation, Heart Failure | Phase 4 | Status: TERMINATED